AbelaPharm Swiss acquires STADA production site in Serbia

The probiotics producer has invested more than €4 million in construction and equipment

picture of

Breaking News

Lonza: Pharma Biotech & Nutrition business performs well

The Swiss CDMO keeps 2019 outlook, expects CH 7.1 billion in sales and announces measures to mitigate headwinds ...

NHF Holdings proposes majority acquisition of Biodelta

Natural Health Farm Holdings will acquire a 51% majority interest in the contract development, manufacturing, and ...

Abattis acquires Pro Natura BV

Entering into a share purchase agreement through a subsidiary, the acquisition signifies a focus on revenue and profit

A new way to buy and sell additives, vitamins and excipients

Swiss Kemiex and Atradius credit insurance launch unique commodity trading platform for the pharmaceutical and ...

AbelaPharm Swiss acquires STADA production site in Serbia

The probiotics producer has invested more than €4 million in construction and equipment

Lonza and Chr. Hansen joint venture taps into microbiome boom

Companies engage in a three-year plan to provide a full supply chain offering for production of bacteria strains for ...

Amyris gets US$10 million from CBD partner Lavvan

Milestone payment is the first in a $300m agreement between the two companies to bring the first fermentation-derived ...

Seaweed extracts specialist Algaia gets new investor

Agrobusiness SAPEC sgps has acquired a 31% stake in the French biomarine company

Should robots pay taxes?

Robot tax? A tax on robotics is as absurd an idea as a tax on pencils

Enhancing enterprise value in nutraceutical and VMS businesses

In a recently issued white paper, the authors explain what they see as some of the key drivers for value creation in ...

DowDuPont enters final stretch of long-awaited split

The chemical giant has announced the names and functions of each of the new spin-off companies

GB Sciences taps into cannabinoid market with new company in Canada

The US-based cannabis business creates new company to target medical, nutraceutical, and prescription drug markets